Early research (Phase 1)Active Not RecruitingNCT07078695What this trial is testingA Trial of SHR-1139 in Healthy VolunteersWho this might be right forPsoriasis Atridia Pty Ltd. 24
Early research (Phase 1)Study completedNCT06929039What this trial is testingOpen Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy SubjectsWho this might be right forRheumatoid Arthritis (RA Kashiv BioSciences, LLC 300
Post-approval studies (Phase 4)Study completedNCT01684072What this trial is testingSafety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without GelatinWho this might be right forChickenpoxZoster Beijing Center for Disease Control and Prevention 1,200
Early research (Phase 1)Looking for participantsNCT07395739What this trial is testingA Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104Who this might be right forNeisseria Meningitidis Serogroup B Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) 30
Large-scale testing (Phase 3)WithdrawnNCT02082639What this trial is testingImmunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 YearsWho this might be right forInfections, Papillomavirus GlaxoSmithKline
Early research (Phase 1)Study completedNCT02459262What this trial is testingSafety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.Who this might be right forInfection by Streptococcus Group B Minervax ApS 240
Large-scale testing (Phase 3)Study completedNCT04470427What this trial is testingEvaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19Who this might be right forSARS-CoV-2 ModernaTX, Inc. 30,415
Post-approval studies (Phase 4)UnknownNCT05131841What this trial is testingCipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBCWho this might be right forMetastatic Breast Cancer Zhejiang Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02213354What this trial is testingH7N9 Mix and Match With MF59 in Healthy Elderly PersonsWho this might be right forAvian Influenza National Institute of Allergy and Infectious Diseases (NIAID) 479
Early research (Phase 1)Not Yet RecruitingNCT07568041What this trial is testingPhase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's PatientsWho this might be right forAlzheimer's Disease (AD) Cenna Biosciences Inc. 54
Not applicableStudy completedNCT00439894What this trial is testingAncillary Study to Protocol 20060104Who this might be right forRheumatoid Arthritis Amgen 50
Testing effectiveness (Phase 2)Ended earlyNCT04684394What this trial is testingA Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular DegenerationRetinal DiseaseRetinal Degeneration+1 more Gemini Therapeutics, Inc. 50
Early research (Phase 1)Active Not RecruitingNCT07791342What this trial is testingA Phase I Study of 9MW4113 Injection Versus Dupixent®Who this might be right forHealthy Participants Mabwell (Shanghai) Bioscience Co., Ltd. 208
Not applicableStudy completedNCT06597370What this trial is testingImmunogenicity Induced by COVID-19 Vaccines in Mexican PopulationWho this might be right forCOVID-19 Vaccine National Polytechnic Institute, Mexico 80
Large-scale testing (Phase 3)Study completedNCT02467842What this trial is testingImmunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly SubjectsWho this might be right forInfluenza SK Chemicals Co., Ltd. 1,503
Large-scale testing (Phase 3)UnknownNCT05015686What this trial is testingSafety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years OldWho this might be right forVaricella Sinovac (Dalian) Vaccine Technology Co., Ltd. 2,400
Post-approval studies (Phase 4)Study completedNCT04852861What this trial is testingCOVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 VaccineWho this might be right forCovid19 Sciensano 145
Early research (Phase 1)Study completedNCT06101173What this trial is testingEvaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy AdultsWho this might be right forPoliomyelitis CanSino Biologics Inc. 72
Early research (Phase 1)Study completedNCT01094873What this trial is testingStudy of a Novel Therapeutic Vaccine for Hepatitis C VirusWho this might be right forHepatitis C ReiThera Srl 35
Testing effectiveness (Phase 2)Looking for participantsNCT06513286What this trial is testingTherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine CandidateWho this might be right forChronic Hepatitis B Michael Hoelscher 81